[Immunohistochemical study of neoplasm-associated proteins in cerebellum medulloblastomas]

Arkh Patol. 1998 Jul-Aug;60(4):8-14.
[Article in Russian]

Abstract

Tumor-associated proteins are studied immunohistochemically in 86 medulloblastomas (MB). Three main variants of their coexpression (70% of all cases studied) are distinguished. The 1st variant (24 cases): expression of Rb and nm23 proteins and the lack of tenascin expression. The 2nd variant (25 cases): tenascin expression and lack of Rb and nm23 expression. The 3rd variant (12 cases): the expression of tenascin, Rb, p53 and/or bc12. Tenascin-positive MB much more frequently expressed oncoproteins p53, bc12, c-erb B-2 and p30/32, and had higher indices of "growth fraction". Tenascin immunoreactivity and that of other oncoproteins prevailed in MB with desmoplasia and in tumors with immunohistochemical features of neuronal differentiation.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers, Tumor*
  • Cerebellar Neoplasms / metabolism*
  • Cerebellar Neoplasms / pathology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Medulloblastoma / metabolism*
  • Medulloblastoma / pathology
  • Monomeric GTP-Binding Proteins*
  • NM23 Nucleoside Diphosphate Kinases
  • Neoplasm Proteins / biosynthesis*
  • Nucleoside-Diphosphate Kinase*
  • Retinoblastoma Protein / biosynthesis
  • Tenascin / biosynthesis
  • Transcription Factors / biosynthesis

Substances

  • Biomarkers, Tumor
  • NM23 Nucleoside Diphosphate Kinases
  • Neoplasm Proteins
  • Retinoblastoma Protein
  • Tenascin
  • Transcription Factors
  • NME1 protein, human
  • Nucleoside-Diphosphate Kinase
  • Monomeric GTP-Binding Proteins